SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-019588
Filing Date
2023-05-24
Accepted
2023-05-24 16:06:54
Documents
13
Period of Report
2023-05-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cort-20230519.htm   iXBRL 8-K 57588
2 EX-3.1 a31restatedcertificateofin.htm EX-3.1 23832
  Complete submission text file 0001628280-23-019588.txt   233973

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20230519.xsd EX-101.SCH 1937
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20230519_lab.xml EX-101.LAB 26345
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20230519_pre.xml EX-101.PRE 13672
7 EXTRACTED XBRL INSTANCE DOCUMENT cort-20230519_htm.xml XML 11545
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 23954152
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences